In short, the result of the imbalance between these three antiangiogenic and pro-angiogenic factors such as PlGF and follistatin is increased endothelial oxidative stress—the likely final pathway underlying the systemic maternal endothelial dysfunction. This evidence concerns the gene PGF and endothelial dysfunction.